Navigation Links
Symposium focuses on curable cancer that affects young men
Date:5/14/2008

The latest information on the biology and treatment of testicular cancer, the most common cancer among young men, will be presented at the Symposium on Testicular Cancer organized by the European Society for Medical Oncology (ESMO), to be held on 15-16 May in Munich, Germany.

"Testicular cancer is the most common tumor in men between the ages of eighteen and thirty-five and has seen the strongest increase in incidence among all cancer types over the last 20 years," said the Symposium's Scientific Chair Prof. Hans-Joachim Schmoll, Director of the Department of Internal Medicine for oncology and hematology at the Martin Luther University Halle and former president of the German association for medical oncology (AIO).

Currently, testicular cancer affects one in every 100 men per year in Europe. The causes of the dramatic rise in incidence remain unclear.

The cure rate for testicular cancer has increased dramatically in recent years, thanks to improvements in chemotherapy. As a result, the treatment strategies in virtually all stages of the disease have changed, away from aggressive surgical or radiation treatment to surveillance without treatment or minimal treatment for most patients in early stages and only limited chemotherapy in advanced stages.

"All these changes in treatment approach mean patients need highly informed and experienced doctors, both to give them the best advice on selecting optimal treatment and then to implement with expertise the adopted course," Prof. Schmoll continued.

The ESMO Symposium on Testicular Cancer will present cutting-edge information on the molecular background of testicular cancer. Sessions will focus on explaining the sensitivity of this tumor to chemotherapy, on prognostic factors and on practical decision-making options for individual patients. In particular, treatment options will be discussed against the background of the European Consensus Guidelines.

After the public meeting, the Symposium Faculty will convene for the ESMO International Consensus meeting on Testicular Tumors, to both elaborate several important topics in the field and to update the ESMO Clinical Recommendations (CR) on Testicular seminoma.

Highlights of the meeting include sessions on the biology of germ cell tumors, with presentations by J. Wolter Oosterhuis from the Netherlands and Ewa Rajpert-De Meyts from Denmark. Darren Feldman from the US will also present brand new data on why germ cell tumors are so platinum sensitive and some resistant.


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
0041-919-731-907
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. 2nd ESMO symposium on soft tissue carcinomas and GIST
2. Smart Balance to Webcast Presentation at Goldman Sachs Consumer Products Symposium
3. Aflac CEO Funds Breast Cancer Symposium in Honor of Companys African-American Female Employees
4. Symposium Targets Critical Manufacturing Topics for Emerging Growth Companies
5. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
6. ATS Medical Announces First Frontiers in Cryoablation Symposium
7. Stem Cells(R) and International Stem Cell Symposium Present Annual Stem Cells(R) Young Investigator Award
8. Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
9. 5W Public Relations Presents the 2008 Body Beautiful Media Symposium Benefiting The Skin Cancer Foundation
10. Symposium to explore role nanoparticles may play in disease
11. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... March 30, 2017 , ... ... Academy of Nutrition and Dietetics (AND), will join nonprofit Seafood Nutrition Partnership (SNP) ... a live webinar designed to help nutrition educators and students inform consumers about ...
(Date:3/29/2017)... ... ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today that Rhino Ag has ... of more than 650 U.S.-based dealers. Rhino, a member of the Alamo Group, offers ... and cutters, rear blades, post hole diggers, pasture renovators, tillers, disc mowers and box ...
(Date:3/29/2017)... ... ... is the main cause of hay fever in the United States, with an estimated 95 ... May to July each year; with the worst time for sufferers being June and July. ... http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent studies ...
(Date:3/29/2017)... ... 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale ... for the remaining days of March, the price will be only $19.97. The EXOUS ... of just $10 (regular retail price $19.97). , The special promotional prices are to ...
(Date:3/29/2017)... ... 29, 2017 , ... Based on research from Guardian’s Fourth ... in trying to balance both short-term and long-term benefits demands. Are employers ... growing complexity, companies are finding that the short-term strategies used to control costs, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Bodycad announced today ... Administration (FDA) 510(k) clearance for its Bodycad Unicompartmental ... truly personalized orthopaedic restoration. Bodycad is the first ... joint reconstruction implant system. Bodycad,s ... personalized restoration of the patient,s unique anatomical features ...
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a clinical ... through treatment, today announced that Carmine N. Stengone , president ... at the Needham & Company 16 th Annual Healthcare Conference ... PDT) at the Westin Grand Central Hotel in New ... ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Market 2014 - 2025" report to their offering. ... The ... 303.7 million by 2025. Increasing geriatric population prone to orthopedic ... orthopedic navigation systems over the forecast period. Osteoarthritis and osteoporosis ...
Breaking Medicine Technology: